APA (7th ed.) Citation

Minter, R., Cohen, E., Wang, B., Liang, M., Vainshtein, I., Rees, G., . . . Sleeman, M. (2013). Protein engineering and preclinical development of a GM- CSF receptor antibody for the treatment of rheumatoid arthritis. British Journal of Pharmacology, 168(1), 200. https://doi.org/10.1111/j.1476-5381.2012.02173.x

Chicago Style (17th ed.) Citation

Minter, RR, et al. "Protein Engineering and Preclinical Development of a GM- CSF Receptor Antibody for the Treatment of Rheumatoid Arthritis." British Journal of Pharmacology 168, no. 1 (2013): 200. https://doi.org/10.1111/j.1476-5381.2012.02173.x.

MLA (9th ed.) Citation

Minter, RR, et al. "Protein Engineering and Preclinical Development of a GM- CSF Receptor Antibody for the Treatment of Rheumatoid Arthritis." British Journal of Pharmacology, vol. 168, no. 1, 2013, p. 200, https://doi.org/10.1111/j.1476-5381.2012.02173.x.